The primary objectives of this research proposal are to identify the molecular components of the immune recognition process involved in allograft rejection. Graft rejection is initiated by T cells of the recipient recognizing antigens of the foreign graft through clonally- expressed TCRs. The basis of this recognition process is the formation of a trimolecular complex consisting of the TCR, MHC molecule (of the recipient and/or donor type), and a peptide derived from metabolically processed graft antigens. The formation of this complex during immune response to the graft initiates a set of intra- and intercellular reactions that result in destruction of the graft. Hence, elucidation of the nature of the trimolecular complex and the subsequent events involved in the graft rejection will not only broaden our understanding of the rejection process, but may also provide a means to induce graft- specific tolerance.
The Specific Aims of this proposal include: 1. Characterization of the TCR repertoire usage by GILs isolated from cardiac allografts performed in rat strain combinations disparate for range of histocompatibility antigens. 2. Establishment of T-cell lines and/or clones from GILs with specific reactivity to graft antigens and examination of their role in mediating cardiac graft rejection following adoptive transfer. 3. Identification of graft antigens that serve as targets for graft- reactive T cells and the analysis of their role in the rejection reaction.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29AI033587-02
Application #
2068639
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1994-05-01
Project End
1995-12-31
Budget Start
1995-05-01
Budget End
1995-12-31
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Cedars-Sinai Medical Center
Department
Type
DUNS #
075307785
City
Los Angeles
State
CA
Country
United States
Zip Code
90048
Shirwan, Haval; Mhoyan, Anna; Kakoulidis, Thanos P et al. (2003) Prevention of chronic rejection with immunoregulatory cells induced by intrathymic immune modulation with class I allopeptides. Am J Transplant 3:581-9
Singh, N P; Shirwan, H (2001) The role of indirect recognition and TH2 response in cardiac xenograft rejection. Transplant Proc 33:746
Yolcu, E; Fang, J; Shirwan, H (2001) Autoimmune responses regulate alloimmunity for prolonged cardiac allograft survival. Transplant Proc 33:93
Cherradi, S L; Shirwan, H (2001) Expression of FasL as a stable cell-surface molecule is important to its apoptotic function. Transplant Proc 33:259
Shirwan, H; Mhoyan, A; Yolcu, E et al. (2001) Intrathymic immune regulation with donor class I allopeptides leads to the development of immunoregulatory cells that maintain tolerance to cardiac allografts. Transplant Proc 33:80
Shirwan, H; Barwari, L; Khan, N S (1999) Immune nonresponsiveness to cardiac allografts by intrathymic inoculation of donor class I allopeptides is associated with high levels of transcripts for Th2 cytokines in the graft. Transplant Proc 31:123-4
Huang, Y; Neipp, M; Ildstad, S T et al. (1999) Rat peripheral T-cell receptor V beta repertoire in F344-to-B10 (rat-to-mouse) mixed xenogeneic chimeras. Transplant Proc 31:978-9
Shirwan, H (1999) Chronic allograft rejection. Do the Th2 cells preferentially induced by indirect alloantigen recognition play a dominant role? Transplantation 68:715-26
Shirwan, H; Barwari, L; Khan, N S (1998) Predominant expression of T helper 2 cytokines and altered expression of T helper 1 cytokines in long-term allograft survival induced by intrathymic immune modulation with donor class I major histocompatibility complex peptides. Transplantation 66:1802-9
Shirwan, H; Wang, C; Barwari, L et al. (1997) Recipient-donor microchimerism is not a prerequisite for the maintenance of allograft tolerance. Transplant Proc 29:1182-3

Showing the most recent 10 out of 20 publications